Stockscreener 앱 받기
7.18
7.81%
0.52
시간 외 거래:
7.08
-0.10
-1.39%
전일 마감가:
$6.66
열려 있는:
$6.69
하루 거래량:
854.58K
Relative Volume:
7.05
시가총액:
$48.69M
수익:
-
순이익/손실:
$-74.14M
주가수익비율:
-0.6304
EPS:
-11.39
순현금흐름:
$-65.70M
1주 성능:
-34.73%
1개월 성능:
-34.25%
6개월 성능:
-69.63%
1년 성능:
-69.28%
1일 변동 폭
$6.68
$7.38
1주일 범위
$5.67
$12.91
52주 변동 폭
$5.67
$42.79
인스틸 바이오 Stock (TIL) Company Profile
명칭
Instil Bio Inc
전화
(972) 499-3350
주소
3963 MAPLE AVENUE, DALLAS
TIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
7.18 | 45.17M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
인스틸 바이오 Stock (TIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-04-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-01 | 다운그레이드 | Truist | Buy → Hold |
| 2021-08-13 | 개시 | Robert W. Baird | Outperform |
| 2021-04-13 | 개시 | Cowen | Outperform |
| 2021-04-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-04-13 | 개시 | Truist | Buy |
모두보기
인스틸 바이오 주식(TIL)의 최신 뉴스
Instil Bio (TIL) Downgraded to Neutral by HC Wainwright & Co. | TIL Stock News - GuruFocus
Instil On The Slide After PD-(L)1xVEGF Exit - Citeline News & Insights
Citizens analyst reiterates Market Perform rating on Instil Bio stock - Investing.com
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M - Investing.com Canada
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco - TipRanks
Instil Bio Terminates License and Collaboration Agreement With ImmuneOnco Biopharmaceuticals - TradingView — Track All Markets
Instil Bio shares slide on discontinuation of lead clinical programs - Proactive financial news
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation By Investing.com - Investing.com South Africa
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation - Investing.com Canada
Instil Bio Halts Main Drug Development Program - Bitget
US Stocks Mixed; Nasdaq Gains Over 50 Points - Benzinga
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco - Fierce Biotech
Instil Bio stock falls after subsidiary discontinues AXN-2510 development By Investing.com - Investing.com Canada
Instil Bio stock falls after subsidiary discontinues AXN-2510 development - Investing.com
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco - The Manila Times
Instil Bio’s Subsidiary Discontinues Clinical Development - GlobeNewswire
(TIL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
IPO Launch: How Zura Bio Limited stock valuations compare to rivalsNew Guidance & Consistent Income Trade Recommendations - moha.gov.vn
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M By Investing.com - Investing.com Nigeria
Citizens analyst reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com Canada
Why analysts remain bullish on Instil Bio Inc. stockREITs Market Trends & High Return Portfolio Growth - bollywoodhelpline.com
Insider Buy: How Instil Bio Inc stock performs after earningsChart Signals & Short-Term Trading Alerts - moha.gov.vn
Rally Mode: Why Instil Bio Inc. stock is favored by top institutionsJuly 2025 Review & High Accuracy Trade Alerts - Улправда
Support Test: Is Instil Bio Inc. stock a good choice for value investorsDividend Hike & Low Drawdown Investment Ideas - Улправда
Will Instil Bio Inc. stock see PE expansionJuly 2025 Price Swings & AI Optimized Trading Strategy Guides - Улправда
Will Instil Bio Inc. stock benefit from green energy trendsJuly 2025 Action & Free High Accuracy Swing Entry Alerts - DonanımHaber
What Wall Street predicts for Instil Bio Inc. stock price2025 Sector Review & Breakout Confirmation Alerts - Улправда
Aug Catalysts: Will Instil Bio Inc. stock outperform Dow Jones indexQuarterly Market Summary & Free Verified High Yield Trade Plans - DonanımHaber
Analyst Downgrade: Is Instil Bio Inc. stock a good choice for value investors2025 Price Action Summary & Weekly Sector Rotation Insights - Улправда
Is Instil Bio Inc. stock attractive for hedge fundsMarket Activity Report & AI Enhanced Trade Execution Alerts - DonanımHaber
Instil Bio Earnings Notes - Trefis
(TIL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Check out Instil Bio's stock price (5GT0-FF) in real time - CNBC
Is Instil Bio Inc a good long term investmentInsider Selling Patterns & Free Stock Trading Workshops - earlytimes.in
Responsive Playbooks and the TIL Inflection - news.stocktradersdaily.com
Instil Bio Inc (TIL) looking to reclaim success with recent performance - Setenews
Operating income of Instil Bio, Inc. – FWB:5GT0 - TradingView
Understanding the Setup: (TIL) and Scalable Risk - news.stocktradersdaily.com
Why Instil Bio Inc. stock is a value investor pickMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Is Instil Bio Inc. showing signs of accumulation2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Working capital per share of Instil Bio, Inc. – FWB:5GT0 - TradingView
Instil Bio, Inc. Balance Sheet – FWB:5GT0 - TradingView
Signal strength of Instil Bio Inc. stock in tech scanners2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Will Instil Bio Inc. stock maintain momentum in 2025Portfolio Gains Report & Proven Capital Preservation Methods - newser.com
How Instil Bio Inc. stock reacts to job market data2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Is Instil Bio Inc. stock attractive for long term wealth buildingJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
What hedge fund activity signals for Instil Bio Inc. stockQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Citizens reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com Australia
Applying Wyckoff theory to Instil Bio Inc. stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-19 03:08:52 - newser.com
인스틸 바이오 (TIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):